194085-75-1 Usage
Description
2-(2-CHLOROPHENYL)-2-HYDROXYETHYL CARBAMATE, also known as Carisbamate, is an antiepileptic agent that has been developed for the adjuvant treatment of partial onset epilepsy. It is effective in reducing spike and wave discharges in the frontoparietal cortex, increasing latency to the first running episode in convulsive seizures, and reducing motor seizure frequency in spontaneous seizures. Carisbamate also exhibits neuroprotective and antiepileptogenic properties in rodent epilepsy models. Its mechanism of action includes blocking Nav1.2 channels and inhibiting repetitive firing of action potentials in rat hippocampal neurons, as well as reducing T-type Ca2+ currents in HEK cells transfected with human recombinant Cav3.1 channels.
Uses
Used in Pharmaceutical Industry:
2-(2-CHLOROPHENYL)-2-HYDROXYETHYL CARBAMATE is used as an antiepileptic agent for the adjuvant treatment of partial onset epilepsy. It is effective in reducing spike and wave discharges, increasing latency to the first running episode in convulsive seizures, and reducing motor seizure frequency in spontaneous seizures due to its ability to block Nav1.2 channels, inhibit repetitive firing of action potentials, and reduce T-type Ca2+ currents.
Additionally, Carisbamate exhibits neuroprotective and antiepileptogenic properties, making it a promising candidate for further research and development in the treatment of epilepsy and potentially other neurological disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 194085-75-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,0,8 and 5 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 194085-75:
(8*1)+(7*9)+(6*4)+(5*0)+(4*8)+(3*5)+(2*7)+(1*5)=161
161 % 10 = 1
So 194085-75-1 is a valid CAS Registry Number.
194085-75-1Relevant articles and documents
IMPROVED PROCESS FOR PREPARING 2-(SUBSTITUTED PHENYOL)-2-HYDROXY-ETHYL-CARBAMATES
-
Page/Page column 7-8; 8, (2009/05/29)
The present invention relates to a process of preparing a compound of Formula I: Wherein R1 is defined in the specification. Compounds of Formula I are useful for treating disorders of the central nervous system, including epilepsy. The process includes a novel use of the reagent lithium borohydride.